Pfizer, Tempus collaborate on cancer drug development
Mobi Health News
MARCH 2, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Mobi Health News
MARCH 2, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Mobi Health News
MAY 28, 2020
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mobi Health News
JANUARY 31, 2023
Cough monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
Mobi Health News
OCTOBER 4, 2022
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
FierceHealthIT
DECEMBER 11, 2020
Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.
FierceHealthIT
JANUARY 20, 2022
Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development. Thu, 01/20/2022 - 17:06.
Mobi Health News
OCTOBER 1, 2020
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.
FierceHealthIT
MAY 3, 2021
Optum: Why payers should be watching flurry of drug development activity around eczema. Mon, 05/03/2021 - 15:53.
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
FierceHealthIT
JULY 11, 2019
Startup Medicare Advantage insurer Clover Health has launched a new drug development subsidiary called Clover Therapeutics.
Mobi Health News
DECEMBER 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Mobi Health News
APRIL 5, 2022
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
Digital Health Global
SEPTEMBER 19, 2023
Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.
Mobi Health News
MAY 19, 2022
They aim to bring down the period and costs for new drug development.
Mobi Health News
JULY 9, 2019
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
KevinMD
MARCH 14, 2019
An important part of advancing medical research and drug development is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population.
Mobi Health News
JULY 10, 2019
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.
Mobi Health News
JULY 15, 2021
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Electronic Health Reporter
APRIL 8, 2022
Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. The article How Technology Is Improving Success Rates In Drug Clinical Trials appeared first on electronichealthreporter.com.
ActiGraph
DECEMBER 27, 2021
During the recent Annual ASCO Meeting , thousands of cancer researchers and clinicians from across the globe joined together virtually to present and discuss the latest findings and breakthroughs in cancer research and care.
Mobi Health News
FEBRUARY 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.
Healthcare IT Today
APRIL 14, 2022
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drug development and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
Healthcare IT Today
MAY 25, 2021
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.
Digital Health Global
MARCH 29, 2023
With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We
Healthcare IT Today
NOVEMBER 24, 2021
The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
Digital Health Global
MARCH 30, 2023
The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drug development process questions the reliability and accuracy of DHT products.
Lloyd Price
MAY 16, 2023
Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Palantir's products are helping these organizations to improve patient care, accelerate research, and improve drug development. What are a few likely scenarios for Palantir in Healthcare? Have a comment?
ActiGraph
FEBRUARY 1, 2023
Drug development success rates have been on the decline since 2015. 1 The machinery of clinical development urgently needs some new oil. Compounded by the pandemic, trial success rates fell to a 10-year low in 2021, averaging only a 5% likelihood of successful progression through all phases.
Healthcare IT Today
APRIL 11, 2023
Here they are producing more accurate and efficient tools for drug development. The biotherapeutics monitoring equipment from 908 Devices illustrates the positive role technology—sensitive measuring devices, analytics, and automation—can play in medicine.
ActiGraph
FEBRUARY 1, 2023
Drug development success rates have been on the decline since 2015. 1 The machinery of clinical development urgently needs some new oil. Compounded by the pandemic, trial success rates fell to a 10-year low in 2021, averaging only a 5% likelihood of successful progression through all phases.
Digital Health Global
AUGUST 30, 2023
QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.
Digital Health Global
JUNE 13, 2023
We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. “The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re
Mobi Health News
APRIL 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated in the round, which brings the company’s total funds raised to over $200 million.
Electronic Health Reporter
SEPTEMBER 17, 2020
As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. Illegal copying is prohibited. By Dimitar Karaivanov, CEO and co-founder, Kanbanize. Without a direct relationship with […].
Digital Health Global
MARCH 2, 2023
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.
Healthcare IT Today
MARCH 23, 2023
“We are excited to announce this funding that supports our mission to enhance the drug development pathway from discovery through commercialization,” said Eran Seger, Co-Founder and CEO at Protai. “I We look forward to scaling our organization and its important work towards revolutionizing the drug development landscape.” “Our
hea!thcare innovation - Clinical IT
MAY 16, 2019
Real-world evidence has the potential to be especially valuable in a number of healthcare use cases
Healthcare IT Today
MAY 22, 2023
.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.
Digital Health Global
JUNE 20, 2023
Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.
Healthcare IT Today
SEPTEMBER 28, 2022
Already, this real-world, distributed time of diagnosis approach, has been used to cut down more than four years of estimated drug development timeline in the instance of PRAX-222, a new therapy for SCN2A, a rare genetic disorder of pediatric epilepsy.
Healthcare IT News - Telehealth
FEBRUARY 11, 2022
The companies drew particular attention to Labcorp Drug Development, which Ascension says it can use to present physicians and patients with access to clinical trials, innovative therapies and new treatment options where appropriate. Labcorp also said it would use proprietary analytic tools and processes to improve overall efficiency.
Healthcare IT Today
NOVEMBER 1, 2022
The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content